Detalhe da pesquisa
1.
Long-term outcome of acute promyelocytic leukemia treated with all-trans-retinoic acid, arsenic trioxide, and gemtuzumab.
Blood
; 129(10): 1275-1283, 2017 03 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28003274
2.
Minimal residual disease assessed by multi-parameter flow cytometry is highly prognostic in adult patients with acute lymphoblastic leukaemia.
Br J Haematol
; 172(3): 392-400, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26492205
3.
Long-term follow-up of a phase 2 study of chemotherapy plus dasatinib for the initial treatment of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia.
Cancer
; 121(23): 4158-64, 2015 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-26308885
4.
The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality.
J Antimicrob Chemother
; 70(8): 2362-8, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-25855759
5.
Retrospective review of vancomycin-induced nephrotoxicity in patients with leukemia.
J Oncol Pharm Pract
; 20(6): 403-8, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24177356
6.
Acute kidney injury in acute promyelocytic leukemia: a possible adverse effect of high dose arsenic trioxide in obese patients.
Leuk Lymphoma
; 65(3): 378-382, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38054837
7.
A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia.
Br J Haematol
; 182(3): 442-444, 2018 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28616864
8.
Azacitidine plus venetoclax in patients with high-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: phase 1 results of a single-centre, dose-escalation, dose-expansion, phase 1-2 study.
Lancet Haematol
; 9(10): e756-e765, 2022 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-36063832
9.
Treatment of FLT3-ITD-positive acute myeloid leukemia relapsing after allogeneic stem cell transplantation with sorafenib.
Biol Blood Marrow Transplant
; 17(12): 1874-7, 2011 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-21767516
10.
Tagraxofusp as treatment for patients with blastic plasmacytoid dendritic cell neoplasm.
Expert Rev Anticancer Ther
; 20(7): 543-550, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32460559
11.
Tagraxofusp, the first CD123-targeted therapy and first targeted treatment for blastic plasmacytoid dendritic cell neoplasm.
Expert Rev Clin Pharmacol
; 12(10): 941-946, 2019 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-31465247
12.
Topoisomerase II inhibitors in AML: past, present, and future.
Expert Opin Pharmacother
; 20(13): 1637-1644, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31136213
13.
Phase II trial of vorinostat with idarubicin and cytarabine for patients with newly diagnosed acute myelogenous leukemia or myelodysplastic syndrome.
J Clin Oncol
; 30(18): 2204-10, 2012 Jun 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22585696
14.
Feasibility of therapy with hypomethylating agents in patients with renal insufficiency.
Clin Lymphoma Myeloma Leuk
; 10(3): 205-10, 2010 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-20511166